Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q1 FY24 results · Apr–Jun 2023
Dr. Lal Path Labs reported revenue from operations of ₹541.00 crore (up 7.6% from Q1 FY23) and net profit of ₹83.60 crore (up 43.6% from Q1 FY23) for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 541.00 | 502.70 | +7.6% | 491.00 | +10.2% |
| Other income | 14.40 | 8.30 | +73.5% | 14.20 | +1.4% |
| Total income | 555.40 | 511.00 | +8.7% | 505.20 | +9.9% |
| Profit before tax | 117.50 | 81.40 | +44.3% | 83.20 | +41.2% |
| Net profit for the period | 83.60 | 58.20 | +43.6% | 56.90 | +46.9% |
| Attributable to shareholders of the company | 82.60 | 57.70 | +43.2% | 56.70 | +45.7% |
| EPS, basic (₹) | 9.95 | 6.97 | +42.8% | 6.84 | +45.5% |
| Net margin (%) | 15.5 | 11.6 | 11.6 |
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 480.10 | 439.30 | +9.3% | 431.00 | +11.4% |
| Other income | 15.00 | 18.80 | −20.2% | 11.60 | +29.3% |
| Total income | 495.10 | 458.10 | +8.1% | 442.60 | +11.9% |
| Profit before tax | 125.10 | 101.70 | +23.0% | 98.10 | +27.5% |
| Net profit for the period | 93.60 | 79.60 | +17.6% | 71.40 | +31.1% |
| EPS, basic (₹) | 11.28 | 9.61 | +17.4% | 8.61 | +31.0% |
| Net margin (%) | 19.5 | 18.1 | 16.6 |
Consolidated
- Filed with BSE
- 27 Jul 2023, 17:32 IST
- Board meeting
- 27 Jul 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 27 Jul 2023, 17:32 IST
- Board meeting
- 27 Jul 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE